<div id="readability-page-1"><p>In a report released on November 12, Anthony Vendetti from Maxim Group maintained a Hold rating on Aethlon Medical. The company’s shares closed yesterday at $4.20.</p><h3>Meet Your ETF AI Analyst</h3><ul><li> Discover how TipRanks' <i>ETF</i> AI Analyst  can help you make smarter investment decisions </li><li>   Explore ETFs TipRanks' users love  and see what insights the <b><i>ETF</i> AI Analyst</b> reveals about the ones you follow.</li></ul> <p>According to TipRanks, Vendetti is an analyst with an average return of <span>-23.2%</span> and a 25.86% success rate. Vendetti covers the Healthcare sector, focusing on stocks such as Lucid Diagnostics, Rockwell Med, and NeuroOne Medical Technologies.</p> <p>The analyst consensus on Aethlon Medical is currently a Hold rating.</p></div>

AEMD

<p>Maxim Group's Anthony Vendetti reaffirmed a Hold rating on Aethlon Medical (AEMD) in a report dated November 12. The stock closed at $4.20. Vendetti, with an average return of -23.2% and a 25.86% success rate, covers the Healthcare sector. The analyst consensus for Aethlon Medical remains a Hold rating.</p>

Maxim Group Reaffirms Their Hold Rating on Aethlon Medical (AEMD)